Department of Oncology-Pathology
The Department of Oncology-Pathology conducts basic, translational and clinical research and educational activities related to cancer.
Menu for this area
News and calendar from OnkPat
More news
Photo: Stefan ZimmermanÅsa Carlsson Tedgren appointed Adjunct Professor in medical radiation physics
We congratulate Åsa Carlsson Tedgren, who as of 1 December 2025 has been appointed Adjunct Professor at the Department of Oncology-Pathology. Åsa leads a research group in clinical radiotherapy, where oncologists and hospital physicists collaborate. The group is primarily based at the Radiotherapy Unit at Karolinska University Hospital and conducts research in several areas, including external radiotherapy and brachytherapy.
Photo: Jan TorbjörnssonIoannis Zerdes appointed docent in oncology
Warm congratulations to Ioannis Zerdes, who was recently appointed docent at the Department of Oncology-Pathology. He obtained his PhD in breast cancer at the department in 2020 and is part of Theodoros Foukakis’s research group. The group conducts clinical studies aiming to understand how treatment resistance develops in breast cancer and to identify novel predictive biomarkers for therapy response.
Photo: PrivatAward for breast cancer treatment research project
The Swedish Society of Medicine’s 2025 award for best scientific project proposal has been granted to Alexios Matikas at the Department of Oncology-Pathology. His research project, “Integrated multi-omics for prediction of response to antibody-drug conjugates”, aims to improve the ability to predict which breast cancer patients are likely to benefit from a specific treatment using antibody-drug conjugates.
Photo: N/ADose-dense chemotherapy improves survival for breast cancer patients
Alexios Matikas and Theodoros Foukakis have published a secondary analysis of the phase 3 PANTHER study in Lancet Regional Health Europe, showing that all patients with operated, lymph node-positive breast cancer benefit from more frequent chemotherapy every two weeks compared to the standard treatment every three weeks.
Related centers
Photo: Creative Commons CC0Cancer Research KI
Cancer Research KI is an overarching umbrella organisation and single point of entry to cancer research at Karolinska Institutet, that includes some 250 research groups. The aim is to bring together top-level cancer scientists from different disciplines, with the overall goal to generate new discoveries that can be rapidly translated into clinical practice for the benefit of patients and society.
Photo: Angiola HarryBRECT - Breast Cancer Theme Center
BRECT aims to increase our understanding of critical steps in breast cancer development and therapy.
KIPCM - The Personalised Cancer Medicine Program
The Personalised Cancer Medicine Program at Karolinska Institutet (KIPCM) is a research initiative with the primary task to strengthen the infrastructure for team science addressing PCM. The core of the work is to bring together researchers at KI and SciLifeLab with clinical researchers at Karolinska University Hospital for PCM team science.
Photo: n/aCancer Core Europe
Karolinska Institutet is one of the seven leading cancer centers that have joined forces to form the European cancer association Cancer Core Europe.
KI operational delegate: Christina von Gertten